Laurion Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-147,646
| Closed | -$492K | – | 337 |
|
|
2023
Q4 | $492K | Buy |
147,646
+17,228
| +13% | +$57.4K | ﹤0.01% | 187 |
|
|
2023
Q3 | $488K | Buy |
+130,418
| New | +$488K | ﹤0.01% | 166 |
|
|
2018
Q3 | – | Sell |
-126,201
| Closed | -$1.77M | – | 807 |
|
|
2018
Q2 | $1.77M | Buy |
126,201
+87,421
| +225% | +$1.22M | 0.01% | 392 |
|
|
2018
Q1 | $428K | Buy |
+38,780
| New | +$428K | ﹤0.01% | 767 |
|